Metformin study for prediabetes halted before it began
Disease control
Terminated
This study aimed to see if metformin improves blood vessel function in adults aged 18-55 with prediabetes. Participants would have taken metformin or a placebo for 12 weeks. However, the study was withdrawn before enrolling anyone, so no results are available.
Phase: PHASE2 • Sponsor: Diana Jalal • Aim: Disease control
Last updated May 14, 2026 12:06 UTC